Source:http://linkedlifedata.com/resource/pubmed/id/19837667
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
50
|
pubmed:dateCreated |
2009-12-7
|
pubmed:abstractText |
IL-8 produced by prostate cancer cells may be responsible for the androgen-independent growth of advanced prostate cancers. Accumulating evidence from microarray analyses and animal genetic models highlights the central involvement of the transcription factor early growth response-1 (EGR-1) in prostate carcinoma progression. It is unknown, however, whether knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated tumor metastasis. Here we show that EGR-1 knockdown by a specific shRNA-Egr1 inhibited gene transcription and production of IL-8 by the human prostate cancer cell line DU145. Conversely, enforced expression of EGR-1 in EGR-1-lacking PC3 prostate cancer cells markedly enhanced IL-8 transcription and secretion. By using wild type and a series of mutant IL-8 promoter luciferase constructs, we found that the NF-kappaB binding site is important for EGR-1 regulation of IL-8. Furthermore, silencing EGR-1 suppressed a synergistically functional interaction between EGR-1 and NF-kappaB. Consequently, knockdown of EGR-1 inhibited IL-8-mediated tumor colony formation and invasion. Thus, targeted knockdown of EGR-1 could be an effective therapeutic approach against prostate cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1083-351X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
11
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
34600-6
|
pubmed:dateRevised |
2010-12-14
|
pubmed:meshHeading |
pubmed-meshheading:19837667-Animals,
pubmed-meshheading:19837667-Cell Line, Tumor,
pubmed-meshheading:19837667-Early Growth Response Protein 1,
pubmed-meshheading:19837667-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:19837667-Gene Knockdown Techniques,
pubmed-meshheading:19837667-Gene Therapy,
pubmed-meshheading:19837667-Humans,
pubmed-meshheading:19837667-Interleukin-8,
pubmed-meshheading:19837667-Male,
pubmed-meshheading:19837667-NF-kappa B,
pubmed-meshheading:19837667-Neoplasm Invasiveness,
pubmed-meshheading:19837667-Promoter Regions, Genetic,
pubmed-meshheading:19837667-Prostatic Neoplasms
|
pubmed:year |
2009
|
pubmed:articleTitle |
Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-1/NF-kappaB synergy.
|
pubmed:affiliation |
Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|